Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.56 +0.00 (+0.72%)
As of: Sep 30, 2026 · 10:23 AM EDT

Citius Pharmaceuticals (CTXR) Current Debt (2013)

Updated

Citius Pharmaceuticals (CTXR) reported Current Debt of -$9.00 for fiscal Q2 2014 (quarter ended Jun 30, 2014).

Analysis

Citius Pharmaceuticals (CTXR) Current Debt (2013) Analysis & Trends

Over the twelve months ended Jun 30, 2014, Citius Pharmaceuticals' Current Debt came in at -$27.00; for FY2013 (ended Sep 30, 2013), it was $9.00.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 37.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Citius Pharmaceuticals 15.10 Mn 24.39 Mn 1.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -9.00
API Access

Citius Pharmaceuticals Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=CTXR&period=max&api_key=YOUR_API_KEY